Paclitaxel - Biosensors International
Alternative Names: Paclitaxel - Occam InternationalLatest Information Update: 15 Jan 2022
Price :
$50 *
At a glance
- Originator Biosensors International Pte Ltd
- Developer Biosensors International Group
- Class Albumins; Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Coronary artery restenosis
Most Recent Events
- 19 Jul 2005 Clinical trials in Coronary artery restenosis in Europe (Intracoronary)
- 19 Jul 2005 Preregistration for Coronary artery restenosis in European Union (Intracoronary)
- 19 Jul 2005 Registered for Coronary artery restenosis in European Union (Intracoronary)